What does CUSIP 868459108 represent in this 13F holders report?

CUSIP 868459108 is the security identifier for SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in Q2 2020?

213 institutional investors reported SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)

CUSIP: 868459108

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock
Shares outstanding: 57,572,193
Total 13F shares: 50,545,295
Share change: +1,543,492
Total reported value: $1,200,362,920
Put/Call ratio: 36%
Price per share: $23.75
Number of holders: 213
Value change: +$48,582,918
Number of buys: 120
Number of sells: 88

Quarterly Holders Quick Answers

What is CUSIP 868459108?
CUSIP 868459108 identifies SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 868459108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	15%	8,554,255	$153,893,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	9.5%	5,463,479	$98,288,000	—	31 Mar 2020	13F
ARMISTICE CAPITAL, LLC	13F	Company	5.2%	3,000,000	$53,970,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	3.2%	1,846,437	$33,217,000	—	31 Mar 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	3.2%	1,816,890	$32,683,000	—	31 Mar 2020	13F
MACQUARIE GROUP LTD	13F	Company	3%	1,728,264	$31,092,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	2%	1,142,109	$20,546,000	—	31 Mar 2020	13F
GLENMEDE TRUST CO NA	13F	Company	1.4%	782,079	$18,549,000	—	31 Mar 2020	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	1.6%	947,555	$17,047,000	—	31 Mar 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.6%	902,200	$16,231,000	—	31 Mar 2020	13F
Invesco Ltd.	13F	Company	1.4%	815,391	$14,669,000	—	31 Mar 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.4%	783,292	$14,091,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.3%	758,343	$13,642,000	—	31 Mar 2020	13F
Aristotle Capital Boston, LLC	13F	Company	1.3%	740,639	$13,324,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	1.2%	713,240	$12,832,000	—	31 Mar 2020	13F
LSV ASSET MANAGEMENT	13F	Company	1.2%	700,266	$12,597,000	—	31 Mar 2020	13F
NORGES BANK	13F	Company	1.2%	698,547	$12,567,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	1.2%	693,226	$12,471,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	1.2%	689,361	$12,402,000	—	31 Mar 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.2%	687,319	$12,365,000	—	31 Mar 2020	13F
ASHFORD CAPITAL MANAGEMENT INC	13F	Company	1%	576,004	$10,362,000	—	31 Mar 2020	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.98%	564,670	$10,158,000	—	31 Mar 2020	13F
Bellevue Group AG	13F	Company	0.96%	552,800	$9,945,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.89%	514,850	$9,262,000	—	31 Mar 2020	13F
FULLER & THALER ASSET MANAGEMENT, INC.	13F	Company	0.87%	501,392	$9,020,000	—	31 Mar 2020	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.78%	451,383	$8,120,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.76%	437,332	$7,867,000	—	31 Mar 2020	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.73%	420,448	$7,565,000	—	31 Mar 2020	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.69%	398,561	$7,170,000	—	31 Mar 2020	13F
Matarin Capital Management, LLC	13F	Company	0.67%	387,985	$6,980,000	—	31 Mar 2020	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.67%	387,260	$6,967,000	—	31 Mar 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.66%	379,800	$6,833,000	—	31 Mar 2020	13F
LOOMIS SAYLES & CO L P	13F	Company	0.65%	375,771	$6,760,000	—	31 Mar 2020	13F
WINTON GROUP Ltd	13F	Company	0.63%	363,200	$6,534,000	—	31 Mar 2020	13F
Bruce & Co., Inc.	13F	Company	0.61%	352,105	$6,334,000	—	31 Mar 2020	13F
Point72 Asset Management, L.P.	13F	Company	0.6%	346,666	$6,237,000	—	31 Mar 2020	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	0.59%	337,935	$6,079,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.56%	320,144	$5,760,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.55%	315,854	$5,682,000	—	31 Mar 2020	13F
S&T BANK/PA	13F	Company	0.53%	305,514	$5,496,000	—	31 Mar 2020	13F
MARSHALL WACE, LLP	13F	Company	0.49%	281,169	$5,058,000	—	31 Mar 2020	13F
Stephens Investment Management Group LLC	13F	Company	0.49%	280,947	$5,054,000	—	31 Mar 2020	13F
S.c.a. Candriam	13F	Individual	0.34%	193,000	$4,475,000	—	31 Mar 2020	13F
ROYCE & ASSOCIATES LP	13F	Company	0.4%	233,002	$4,192,000	—	31 Mar 2020	13F
SCOUT INVESTMENTS, INC.	13F	Company	0.4%	230,765	$4,151,000	—	31 Mar 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.4%	228,478	$4,111,000	—	31 Mar 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.36%	206,962	$3,723,000	—	31 Mar 2020	13F
CAPITAL MANAGEMENT CORP /VA	13F	Company	0.34%	195,489	$3,517,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.29%	167,936	$3,021,000	—	31 Mar 2020	13F
CREDIT SUISSE AG/	13F	Company	0.29%	167,775	$3,019,000	—	31 Mar 2020	13F

Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q2 2020

As of 30 Jun 2020, SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) was held by 213 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 50,545,295 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, DIMENSIONAL FUND ADVISORS LP, MACQUARIE GROUP LTD, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, Aristotle Capital Boston, LLC, FULLER & THALER ASSET MANAGEMENT, INC., and RICE HALL JAMES & ASSOCIATES, LLC. This page lists 213 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

199

Q2 2020 holders

213

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.